Lymphoscintigraphy is a nuclear medicine imaging test that maps your lymphatic system using a small amount of radioactive tracer. It produces images showing how fluid moves through your lymphatic channels and where it drains, giving doctors information that no other imaging test can provide. The procedure is most commonly used for two purposes: diagnosing lymphedema and locating sentinel lymph nodes before cancer surgery.
How the Test Works
The test relies on a simple principle: a radioactive tracer injected just under the skin gets picked up by your lymphatic vessels and carried along the same routes your lymph fluid normally travels. A specialized camera then tracks the tracer’s movement and creates a map of your lymphatic drainage pathways.
The tracer used in nearly all cases is a form of technetium-99m sulfur colloid, a radioactive compound with a short half-life that’s been used safely in nuclear medicine for decades. The particles are small enough to enter your lymphatic channels but large enough to get trapped in lymph nodes along the way, which is exactly what makes them useful for imaging. The total radiation exposure from the procedure is roughly 1.0 millisievert, comparable to a few months of natural background radiation.
Why Doctors Order It
Sentinel Lymph Node Mapping
In cancers like melanoma and breast cancer, surgeons need to know whether cancer has spread to nearby lymph nodes. Rather than removing many nodes and examining them all, lymphoscintigraphy identifies the “sentinel” node, the first lymph node that receives drainage from the tumor site. If that node is cancer-free, the others almost certainly are too. This approach, endorsed by both the European Association of Nuclear Medicine and the Society of Nuclear Medicine and Molecular Imaging, has become a standard staging tool that spares patients from more extensive surgery and its side effects.
Diagnosing Lymphedema
When a limb is swollen and doctors suspect the lymphatic system isn’t draining properly, lymphoscintigraphy can confirm the diagnosis and show how severe the problem is. The test reveals whether lymphatic channels are functioning, blocked, or absent. One key finding doctors look for is called dermal backflow, a pattern where lymph fluid reverses direction and spreads into the skin’s tiny surface vessels instead of flowing through its normal deeper channels. This happens when lymphatic valves fail or pathways become obstructed, forcing the fluid to find alternative routes.
The extent of dermal backflow correlates directly with how advanced the lymphedema is. In mild cases, backflow appears in small, localized patches because some lymphatic collectors still work normally. In severe lymphedema, most collectors have stopped functioning, and backflow areas become widespread. This information helps guide treatment decisions and track whether the condition is progressing.
What Happens During the Procedure
No fasting is required before a lymphoscintigraphy scan. You can eat normally and take your regular medications. The only preparation involves providing your medical team with relevant clinical history, including any previous biopsy results or surgeries in the area being studied.
The procedure begins with small injections of the radioactive tracer. The injection site depends on what’s being evaluated. For sentinel lymph node mapping, the tracer is injected near the tumor or biopsy site. For lymphedema evaluation, injections typically go into the web spaces between your fingers or toes, since these areas have dense networks of lymphatic vessels that efficiently pick up the tracer. A topical numbing cream or cold spray can be applied beforehand to reduce discomfort from the injections.
After injection, you’ll lie under a gamma camera that detects the radiation emitted by the tracer as it moves through your lymphatic system. Initial images are often taken within the first few minutes. For sentinel lymph node mapping, imaging at around 30 minutes after injection is generally considered the optimal time, though delayed images at 60, 90, or even 180 minutes may be taken if the target node doesn’t appear right away. Some protocols involve imaging at intervals of 5, 10, and 30 minutes until the sentinel node becomes visible. For lymphedema studies, the imaging timeline may be longer to fully evaluate how the tracer moves through the limbs.
When lymphoscintigraphy is done before surgery, the timing of the injection is coordinated with the planned operation so the tracer is still detectable when the surgeon is ready to locate the sentinel node in the operating room.
Safety and Side Effects
Lymphoscintigraphy is a low-risk procedure. The radiation dose is minimal at roughly 1.0 millisievert, which is far below the threshold associated with any measurable health risk. The most common complaint is mild discomfort at the injection site, particularly with intradermal injections between the fingers or toes. Allergic reactions to the tracer are rare.
Pregnancy and breastfeeding are relative contraindications, meaning the test can still be performed if the clinical benefit justifies it. The amount of radioactive material that transfers into breast milk is very low. As a precaution, many facilities recommend pausing breastfeeding for 24 hours after the injection. For pregnant patients, the decision to proceed is made on a case-by-case basis, weighing the diagnostic benefit against the minimal fetal exposure, and postponing the exam is always considered when possible.
What the Results Show
Normal lymphoscintigraphy images show the tracer traveling smoothly through well-defined lymphatic channels and accumulating in lymph nodes within a predictable timeframe. Abnormal findings can take several forms. Delayed movement of the tracer suggests sluggish lymphatic function. Complete absence of tracer in expected lymph nodes may indicate a blockage or missing nodes, which can occur after surgery or radiation therapy. Asymmetric drainage, where one side of the body drains much more slowly than the other, is another common sign of lymphatic dysfunction.
For sentinel node mapping, the results are more straightforward: the images pinpoint which lymph node (or nodes) receive drainage first from the tumor area. Occasionally, drainage flows to unexpected locations, which is exactly why the mapping is valuable. Without it, a surgeon might look in the wrong place entirely.